
ãã¡ã€ã¶ãŒã® ã人éã«å¯Ÿããç¯çœªã-ãããŠãããå ±éããªãã¬ã¬ã·ãŒã»ã¡ãã£ã¢
å èšäºã¯ãã¡ããã/Click here to read the original article.
ãã¡ã€ã¶ãŒç€Ÿã¯ãCOVID-19ã¯ã¯ãã³ã®èšåºè©Šéšã®äžååããšããã®ã¯ã¯ãã³ã«èŠãããå€ãã®æ·±å»ãªå¯äœçšã«ã€ããŠç¥ã£ãŠãããããããFDAã¯ãšã«ãããã®ã¯ã¯ãã³ã宣äŒããåŸã«ãã®ããŒã¿ãé èœããããšãããšãããã¡ã€ã¶ãŒææžãã®ç·šéè ã§ããããªãã»ãŠã«ãã¯èšãïŒ ãã¡ã€ã¶ãŒã»ããŒããŒïŒãã¡ã€ã¶ãŒã®äººé¡ã«å¯Ÿããç¯çœª "ã®ç·šéè ã§ããããªãã»ãŠã«ãã«ããã°ã
ãŠã«ãã¯ããã£ãã§ã³ããŒãèªãšã®ã€ã³ã¿ãã¥ãŒã§ããã¡ã€ã¶ãŒãšFDAã2021幎åé ãŸã§ã«ç¥ã£ãŠããã¯ã¯ãã³ã«é¢é£ããæ·±å»ãªå·å®³ã«ã€ããŠããã¡ã€ã¶ãŒã®èšåºè©Šéšãšåžè²©åŸèª¿æ»ã®ããŒã¿ã«åºã¥ããŠè©³è¿°ããã
The Pfizer Papersããäœæããããã«ããžã£ãŒããªã¹ãã§ããDaily Cloutã®CEOã§ãããŠã«ããšDaily Cloutã®ããŒãã»ãªãã¬ãŒã·ã§ã³ã»ãªãã£ãµãŒã§ãããšã€ããŒã»ã±ãªãŒã¯ãäœå人ãã®ãã©ã³ãã£ã¢ã®ç§åŠè ãšå»åž«ãæéããã¯ã¯ãã³ã®åœ±é¿ã®å šå®¹ãææ¡ããããã«ããã¡ã€ã¶ãŒã®ããŒã¿ãšä»ã®å ¬çå ±åã·ã¹ãã ããã®è£è¶³ããŒã¿ãåæããã
ãŠã«ããšã±ãªãŒã¯ãFDAãæ å ±å ¬éæ³ã®èŠè«ã«å¿ããªãã£ãããã2021幎ã«FDAãæèšŽããŠããŒã¿ã®å ¬éãè¿«ã£ã30人以äžã®å»çå°éå®¶ãšç§åŠè ãããªãã°ã«ãŒããéææ§ã®ããã®å ¬è¡è¡çãšå»çå°éå®¶ãããããŒã¿ãå ¥æããã
2022幎ãé£éŠè£å€æã¯FDAã«å¯Ÿãããã¡ã€ã¶ãŒãšãã€ãªã³ããã¯ã®COVID-19ã¯ã¯ãã³ã®ã©ã€ã»ã³ã¹äŸäžã«é¢ãã45äžä»¶ã®å éšææžãå ¬éããããåœããã
ããã¡ã€ã¶ãŒè£œè¬ã®è«æãã«åç¬ã§æããžã£ãŒããªã¹ãã¯ããªã
ãŠã«ãã¯äœå幎ãã®éããªãã©ã«ãªã¬ã¬ã·ãŒã¡ãã£ã¢ã§ãžã£ãŒããªã¹ããšããŠåããŠããã2020幎ãç·æ¥äºæ 宣èšãè£ ã£ãŠéäŒã®èªç±ããã®ä»ã®èªç±ã忢ãããã®ãç®ã®åœããã«ãã圌女ã¯ãã¢ã¡ãªã«äººã«èª²ããããæ²æ³éåã声é«ã«æ¹å€ããããã«ãªã£ããšãããã£ãã§ã³ããŒãèªã«èªã£ãã
ãŠã«ãã¯COVID-19ã¯ã¯ãã³ã«ã€ããŠãåæ§ã«æ¹å€çã§ããã人ã ã«ç·æ¥äœ¿çšãèš±å¯ãããäºé²æ¥çš®ãåããããããã«ã€ã³ã»ã³ãã£ããåºã䜿ãããŠããããšã«èŠéã鳎ãããããç§ã¯å»åž«ã§ãç§åŠè ã§ããããŸããããç§ã¯å»åŠè ã§ãç§åŠè ã§ããããŸãããçæ°ã®æ²æ±°ã§ããã
2021幎6æããŠã«ãã¯ã泚å°ãæã£ãåŸã«æçµèª¿ç¯é害ã«èŠãã女æ§ãåºãå ±åãããŠããããšã«æžå¿µããã€ãŒãããã圌女ã¯ãããªã調æ»ãæ±ããã
ãç¿æ¥ããã«ãç§ã¯ãããããœãŒã·ã£ã«ã¡ãã£ã¢ããåé€ãããŸããããã»ãŒåãå 容ã®èšäºããã»ãŒãã¹ãŠã®äž»èŠãªãã¥ãŒã¹ã¡ãã£ã¢ã§åæã«æ²èŒãããŸããã
ãäžçäžã§ãããããèšèªã§ãç§ã¯äžå€ã«ããŠåã¯ã¯ãã³è«è ã®é°è¬è«è ã«ä»ç«ãŠäžããããããšåœŒå¥³ã¯èªã£ãã
ãŠã«ãã¯ã¬ã¬ã·ãŒã¡ãã£ã¢ãã远æŸãããããæ°ããªæãéããããã¹ãã£ãŒãã»ããã³ã¯ç§ããThe War Roomãã«æåŸ ãããã©ãããã©ãŒã ãäžããŠããããããã§åœŒå¥³ã¯ãFDAãå ¬è¡šãããã¡ã€ã¶ãŒã®ææžããµããã«ãããææŠã«ã€ããŠèªã£ãã
ããŒã¿å ¬éã¯èšå¿µç¢çãªãã®ã§ãææžã¯é«åºŠã«æè¡çãã€ç§åŠçãªãã®ã ã£ããããã®ãã¹ãŠã«ç®ãéãããšã®ã§ãããžã£ãŒããªã¹ãã¯ããªãã§ãããããšãŠã«ãã¯èšã£ãã
ããã³ã¯åœŒå¥³ã«ãç§åŠè ã®ãã©ã³ãã£ã¢ããŒã ãçµç¹ãããã®ä»»ã«ãããããããšãææ¡ããããŠã«ããåŒã³ããããšããã3,250人ã®é«åºŠãªè³æ Œãæã€ç§åŠè ãå¿ãããã±ãªãŒã¯åœŒããã¯ãŒãã³ã°ã°ã«ãŒãã«çµç¹ãããŠã«ãããèšé²ãããæŽå²äžã人é¡ã«å¯Ÿããæå€§ã®ç¯çœªã§ããããšã倿ããããšè¿°ã¹ãããšã«ã€ããŠãéèŠãªå ±åæžãçµç¹çã«çºè¡šããã
ããã¡ã€ã¶ãŒç€Ÿã®ææžã¯ãæ³åŸãšã¢ã¡ãªã«äººã®å®éã®å¥åº·ããŸã£ããç¡èŠãããäŒæ¥ã®è²ªæ¬²ããšäžæ£çŽãã®é©ãã¹ãæŽé²ã§ããã
人éã«å¯Ÿãã眪
ãŠã«ãã¯ãç¥ç¶æ¯ãããã³ãŒã¹ãã§8人ã®å åŒã倱ã£ãŠãããããã人éã«å¯Ÿãã眪ããšããèšèã軜ã ãã䜿ãããšã¯ãªããšããã£ãã§ã³ããŒãã«èªã£ãããããããã®å ±åæžã¯ããã¡ã€ã¶ãŒç€ŸãmRNA COVID-19泚å°ã«ãã人äœãžã®è¢«å®³ã«ã€ããŠç¥ã£ãŠããããšãèããã°ããããã¯äžæ³šæã§ããªãã貪欲ã§ããªãã補é å·¥å Žã®ããããã§ããªããšçµè«ããªãããã«ã¯ãããªãããšåœŒå¥³ã¯èšãã
ãæè¡çã§èšãããããã«ããããã¯ãã°ã§ã¯ãªããæ©èœã§ãããããèšãæããã°ãéåžžã«ç¹ç°çãªæ¹æ³ã§ãéåžžã«æ©ã段éã§ãããã«ãã¡ãŒãžãäžããããšã¯ãæããã«ãããã®æ³šå°ã®çµæã§ãã£ãããããŠããã®æ³šå°ãäžæ¢ããããåžå Žããæ€éãããããã代ããã«ããã¡ã€ã¶ãŒç€Ÿã¯åè¿ãããFDAãåè¿ãããCDCïŒçŸç 管çäºé²ã»ã³ã¿ãŒïŒãåè¿ãããã®ã§ããã
ãŠã«ãã«ããã°ããã¡ã€ã¶ãŒç€ŸãFDAãCDCã¯ãæåã®3ã¶æã§1,223人ãäºé²æ³šå°ã§æ»äº¡ããããšãç¥ããªããããã®ãããªæ±ºå®ãäžããããŠã«ãã«ããã°ããã¡ã€ã¶ãŒç€ŸãFDAãCDCã¯ãã¯ã¯ãã³ãææãé£ãæ¢ãããäœäžäººãã®äººã ã«é節ãªå¯äœçšãåŒãèµ·ãããããšãç¥ããªããããã®ãããªæ±ºå®ãäžãããšã®ããšã§ããã
ãã¡ã€ã¶ãŒç€Ÿã¯ãŸããFDAã«ç·æ¥äœ¿çšæ¿èªïŒEUAïŒã®çœ²åãåŸãããã«ããŒã¿ãæäœããããšåœŒå¥³ã¯èšãããŠã«ãã ããã®æ¬ã®äžã§æãäžæå¿«ãªå ±åã®äžã€ ããšåŒãã ããªãŒã¹ãã©ãªã¢ã®éº»é ç§å»ãžã§ã€ã³ãã£ã»ã¯ãããµã³å士ã®ç ç©¶ããŒã ã¯ããã¡ã€ã¶ãŒç€ŸãEUAã®ããŒã¿æåºã®äžéšãšããŠå«ããå¿ èŠããªãããã«ãæ»äº¡ã®èšé²ãé ãããŠããããšãçºèŠããã
ç ç©¶è ãã¡ã¯ããããã¡ã€ã¶ãŒç€Ÿãã¿ã€ã ãªãŒã«æ»äº¡ãèšé²ãå ±åããŠããã°ãFDAã¯ãã®ã¯ã¯ãã³ã®EUAãæ¿èªã§ããªãã£ãã ãããšçµè«ã¥ããã
3ã«æéã§42,000ä»¶ã®éç¯€ãªæå®³äºè±¡ããã®ã»ãšãã©ã女æ§
ãã¡ã€ã¶ãŒã»ããŒããŒãã®ã¢ããªã¹ãã¯ã2020幎12æã®EUAåŸã®æåã®3ã¶æéã«ãã¡ã€ã¶ãŒç€Ÿã«å ±åããã158,893ä»¶ã®æå®³äºè±¡ã詳述ãã42,000件以äžã®çäŸå ±åãçºèŠããã倧éã®å ±åæžãåŠçããããã«ãå瀟ã¯600人ã®åŸæ¥å¡ã远å ãã2021幎6æãŸã§ã«åèš1,800人ãéçšããèšç»ã§ããããšãææžã§ç€ºãããã
ãŠã«ãã¯èšãïŒ
ãè¡æ ãèºè¡æ ãäžè¢è¡æ ãç¥çµé害ããŠããããèªç¥çãã¢ã«ããã€ããŒããã«éº»çºãæ¯æŠãçæ£ãèé害ãè é害ãè³åäžãéåžžã«å€ãã®çš®é¡ã®ç®èçºç¹ãçŒé害ã倱æãåŒåžåšçŸæ£ãªã©ã§ããã
æãå€ãã£ãå¯äœçšã¯çèçã§ã2çªç®ã«å€ãã£ãå¯äœçšã¯é¢ç¯çã§ãã£ãã3çªç®ã«å€ãã£ãå¯äœçšã¯COVID-19ã§ãããã¯ã¯ã¯ãã³ãææãæ¢ããªãã£ãããã§ããã
ããããããã¡ã€ã¶ãŒææžãã® ãç®ç ãã¯ããã¡ã€ã¶ãŒç€Ÿã«ããããã®çæ®ã«é¢ããå®éšã§ããããšãŠã«ãã¯èšãããã¡ã€ã¶ãŒç€Ÿã¯æ©ãããããã®äºé²æ³šå°ãå€§èŠæš¡ãªæçµé害ãåŒãèµ·ããããšãç¥ã£ãŠããããšãŠã«ãã¯èšãã
å瀟ã¯FDAã«ãèšé²ãããæå®³äºè±¡ã®72ïŒ ã女æ§ã§ãã£ããšå ±åããŠããããã®ãã¡ã®çŽ16ïŒ ãçæ®æ©èœé害ã§ãã£ãã
è«æã«ããã°ãèšåºè©Šéšã«ãããŠãäœå人ãã®å¥³æ§ãæ¯æ¥ã®ããã«åºè¡ãäžè¡ãçµç¹ã®ééãçµéšããäœå人ãã®å¥³æ§ãæçµåšæãå®å šã«æ¢ãŸã£ããšå ±åããŠããã
ã圌ãã¯èªåãã¡ã女æ§ãç Žæ» ãããŠããããšãç¥ã£ãŠããã®ã§ãã
ãã¡ã€ã¶ãŒç€Ÿã¯ãã¯ã¯ãã³æ¥çš®ãåããç·æ§ã«å¯ŸããåŠåš å¯èœãªå¹Žéœ¢ã®å¥³æ§ãšã¯æ§äº€ãããªãããã«ããŸããããæ§äº€ãããã®ã§ããã°ãä¿¡é Œã§ãã2çš®é¡ã®é¿åŠæ³ã䜿çšããããã«ãšãŸã§èšã£ãããšåœŒå¥³ã¯ä»ãå ããã
èµ€ã¡ãããžã®åœ±é¿ã¯ãéãåãããã
ãã¡ã€ã¶ãŒç€Ÿã¯ã泚å°ã«ããè質ããç²åãåµå·£ã«èç©ããèç€é¢éãééããŠèç€ãå·ã€ããèå ã®èµ€ã¡ããã«æ é€ãäžããªãããšãèªèããŠããããšãŠã«ãã¯èšãã
èµ€ã¡ããã¯æ©æã«åºç£ããããåŸãªããªãã女æ§ã¯åºç£æã«åºè¡ããã
è«æã«ããã°ãç²åãçŸèãç·ã®åã®ç²Ÿå·£ã®åšãã®èã«å ¥ã蟌ãã ãšããããšã§ããããã®ç·å ãžã®å°æ¥çãªåœ±é¿ã¯æªç¥æ°ã§ããã
è«æã®äžã§æãæ°ã«ãªãå ±åã®ã²ãšã€ã¯ãåŠåš æä¹³æã®å ±åã§ããããã®å ±åæžã«ã¯ãæè¿äºé²æ¥çš®ãåããæ¯èŠªã®æä¹³äžã®èµ€ã¡ãããžã®åœ±é¿ãæžãããŠãããçºç±ãååãæµ®è «ãçµç¹ã®è «ããªã©ãå€ãã®åé¡ãå«ãŸããŠããã
ãããèµ€ã¡ããã¯çæ£ãèµ·ãããå€èåšäžå šã§ç é¢ã§äº¡ããªããŸãããããããã®èµ€ã¡ããã¯æ²åã«ãããŠããŸããã圌ãïŒãã¡ã€ã¶ãŒç€ŸïŒã¯æ¯ä¹³ãæ±æããŠããããšãç¥ã£ãŠããã
ãã®å ±åæžã«ã¯ãèå ã§æ»äº¡ãã2人ã®èµ€ã¡ããã«ã€ããŠã®èšè¿°ãããããã¡ã€ã¶ãŒç€Ÿã¯æ¯èŠªã®ã¯ã¯ãã³æé²ãåå ã§ãããšçµè«ã¥ãããšããã
ãã¡ã€ã¶ãŒç€Ÿã¯2021幎4æ20æ¥ã女æ§ãšèµ€ã¡ããã«å¯Ÿããã¯ã¯ãã³ã®åœ±é¿ã詳述ããåŠåš ã»æä¹³æå ±åæžãFDAã«éã£ãããã®2æ¥åŸãCDCã®ãã·ã§ã«ã»ã¯ã¬ã³ã¹ããŒæé·ã¯ ãã¯ã€ãããŠã¹ã§èšè äŒèŠããåŠåš åãåŠåš äžãåŠåš åŸãåãããCOVID-19ã®æ¥çš®ã«æªãææã¯ãªããšè¿°ã¹ãã
ã¬ã¬ã·ãŒã¡ãã£ã¢ãå ±éããªããªããäœã®æå³ãããã®ãïŒ
Googleã§ ãThe Pfizer Papers ããæ€çŽ¢ãããšãã¹ãã³ãµãŒã®ã€ããŠããªãæåã®æ€çŽ¢çµæã¯ããFighting Harmful Effects of Covid Vaccine Misinformation ããšé¡ããããã¡ã€ã¶ãŒã®ãŠã§ãããŒãžã§ããã®åŸã«COVID-19ã¯ã¯ãã³ã®æå¹æ§ãšå¹æã«é¢ããã©ã³ã»ããã®è«æãç¶ãã
ãŠã«ãã¯ããã®çš®ã®æ€é²ãšã¯ã圌女ãæåã«ããã©ãããã©ãŒã ãããŠä»¥æ¥ãæŠã£ãŠãããšããã
ããžã£ãŒããªã¹ããšããŠãç§ã«ãšã£ãŠç Žå£çã«è ¹ç«ãããã®ã¯ãããã21äžç޿倧ã®ãã¥ãŒã¹ã§ããã«ããããããããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºçŽãšã¯ã·ã³ãã³ã»ãã¹ãçŽãäœãããŠãããªãããšã§ãã
ãå¯äžã®å ±éã¯ä»£æ¿ã¡ãã£ã¢ããã®ãã®ã§ãããèžã匵ãè£ãããã§ãããã¬ã¬ã·ãŒã»ã¡ãã£ã¢ãå ±éããªããªããäœã®æå³ãããã®ã§ãããïŒ
ãŠã«ãã¯ãããã¡ã€ã¶ãŒããŒããŒãº ãã®ã¬ããŒãã¯ãã¡ã€ã¶ãŒã®ããŒã¿ã®èŠçŽã§ãããäžæ¬¡è³æã«ãªã³ã¯ããŠãããããåŠå®ããããšã¯ã§ããªããšè¿°ã¹ããè§£éã§ã¯ãªãã®ã§ããç§åŠè ãå»åž«ã®æèŠã§ã¯ãªãã®ã§ãã
ãããã®ç§åŠè ãå»åž«ã¯äººé¡ã«å¥ä»ããŠããã
ãŠã«ãã¯ããã® ãæãããç¯çœªã®æé¬±ãªæŠèг ãã®äžã§ãããã¡ã€ã¶ãŒææžãã¯ã¯ã¯ãã³è¢«å®³è ã«åžæãäžãããã®ã§ããããšè¿°ã¹ãã
å€ãã®å Žåãå°éå®¶ã®åæãããã¯ã¯ãã³ãã©ã®ããã«è¢«å®³ãããããããã«ã€ããŠã®è©³çްãªèª¬æããªãããããŠã«ãã¯èšãããã©ã®ããã«ããŠè¢«å®³ãçããããçè§£ããããšã¯ããã®çš®ã®è¢«å®³ãã©ã®ããã«æ²»çããããçè§£ããã®ã«åœ¹ç«ã¡ãŸããã
ççç¶æ ã¯ãé£äºããã®ä»ã®ç¿æ £ãå€ããããšã«ãã£ãŠç·©åããããšãã§ããããšåœŒå¥³ã¯èšããè¡æ¶²ååºããã®ä»ã®è¡æ¶²ã®åé¡ã«çŽé¢ããŠãããã¹ãŠã®äººã ã®ããã«ãå¥åº·çãªè¡æµããµããŒãããæ¹æ³ãããã
ãããã¯ãã人äœã«å¯Ÿããéåžžã«æŽç·Žãããæ»æã«å¯Ÿãããéåžžã«ç²éãªåæå¯Ÿå¿ãã®äžäŸãããããªãããšåœŒå¥³ã¯èšããããããç§ã«ãšã£ãŠã¯éåžžã«åžæãæãŠããã®ã§ãã
圌女ã¯ããä»ãå ããïŒ
ãç§åŠè ãå»åž«ãã¡ã¯ããã®çç©å µåšãã©ã®ããã«äººäœã®ããããã·ã¹ãã ãç¹çްã«å·ã€ããŠããã®ããæ·±ãåæããŠããã
ããããæ¬åœã«çè§£ããããšã§ãã©ãããã°ããã¡ãŒãžãåãããããšãã§ããã®ããå ã«æ»ãããšãã§ããã®ãããããã®ã§ãããããå¯èœãã©ããã¯ããããªãã......ã